EUVIMEDEUVIMED entdecken
Crossref

Swertisin improves Alzheimer's disease-like pathology in 5XFAD male mice through regulation in plasmin activity

Somin Moon, Huiyoung Kwon, Eunbi Cho, Seungheon Lee, Se Jin Park, Minho Moon, Jong Hoon Ryu, Dae Sik Jang, Ho Jung Bae, Dong Hyun Kim

Neurochemistry International · 2026-02 · 193 · 106118

DOI: 10.1016/j.neuint.2026.106118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2026-02. Verfasst von Somin Moon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Translational Medicine, Graduate School, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Fibrinolysin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Ministry of Education, National Research Foundation of Korea, National Institute for International Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal accumulation of amyloid β (Aβ), which may result from excessive production or impaired clearance, is one of the pathomechanisms of Alzheimer's disease (AD). Plasmin is one of the important proteases involved in the Aβ clearance system. In this study, we investigated whether swertisin can regulate plasmin activity and reduce Aβ pathology. First, we examined whether swertisin regulated plasmin activity, mature brain-derived neurotrophic factor (mBDNF) levels, and plasminogen activator inhibitor-1 (PAI-1) activity in vitro. Next, we assessed the effect of swertisin on memory impairments in an Aβ-injected AD-like mouse model and in 5XFAD mice. To evaluate the involvement of plasmin in the effect of swertisin in the Aβ-injected AD-like mouse model, we used 6-aminocaproic acid (6-AA), a plasmin inhibitor. Additionally, we measured plasmin activity and mBDNF levels in the hippocampus of Aβ-injected AD-like mice and 5XFAD mice. Swertisin increased plasmin activity and mBDNF levels in hippocampal slices from both normal and 5XFAD mice. Moreover, swertisin ameliorated Aβ-induced synaptic long-term potentiation (LTP) deficits in hippocampal slices. Swertisin also mitigated memory impairments induced by ventricular injection of Aβ, and this effect was blocked by 6-AA. Furthermore, swertisin improved learning and memory in 5XFAD mice while reducing Aβ deposition and neuroinflammation. This study demonstrates that swertisin ameliorates AD-like pathology by regulating plasmin activity. Plasmin activated by swertisin may cleave Aβ aggregates and increase mBDNF levels, thereby protecting the brain from Aβ toxicity. Swertisin may represent an effective therapeutic strategy for AD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseFibrinolysinAnimalsMaleMiceMice, TransgenicAmyloid beta-PeptidesBrain-Derived Neurotrophic FactorHippocampus

Stichwörter der Autor:innen

Alzheimer's diseasePlasminPlasminogen activator inhibitor-1Swertisin

Substanzen

FibrinolysinAmyloid beta-PeptidesBrain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • Department of Advanced Translational Medicine, Graduate School, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, Republic of Korea.
  • Global Institute for Advanced Nanoscience & Technology (GIANT), Changwon National Univerisy, Changwon, 51140, Republic of Korea.
  • Department of Marine Life Sciences, Jeju National University, Jeju, 63243, Republic of Korea.
  • School of Natural Resources and Environmental Sciences, Kangwon National University, Chuncheon, 24341, Republic of Korea.
  • Department of Biochemistry, College of Medicine, Konyang University, Daejeon, 35365, Republic of Korea.
  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.

Förderung

  • Ministry of Education
  • National Research Foundation of Korea
  • National Institute for International Education

Zitieren

APA

Moon, S., Kwon, H., Cho, E., Lee, S., Park, S. J., Moon, M., Ryu, J. H., Jang, D. S., Bae, H. J., & Kim, D. H. (2026). Swertisin improves Alzheimer's disease-like pathology in 5XFAD male mice through regulation in plasmin activity. Neurochemistry International, 193, 106118. https://doi.org/10.1016/j.neuint.2026.106118

Vancouver

Moon S, Kwon H, Cho E, Lee S, Park SJ, Moon M, et al. Swertisin improves Alzheimer's disease-like pathology in 5XFAD male mice through regulation in plasmin activity. Neurochemistry International. 2026;193:106118. doi:10.1016/j.neuint.2026.106118

BibTeX
@article{Moon2026,
  author = {Moon, Somin and Kwon, Huiyoung and Cho, Eunbi and Lee, Seungheon and Park, Se Jin and Moon, Minho and Ryu, Jong Hoon and Jang, Dae Sik and Bae, Ho Jung and Kim, Dong Hyun},
  title = {Swertisin improves Alzheimer's disease-like pathology in 5XFAD male mice through regulation in plasmin activity},
  journal = {Neurochemistry International},
  year = {2026},
  volume = {193},
  pages = {106118},
  doi = {10.1016/j.neuint.2026.106118}
}
Kostenlos starten →